TSHA
Taysha Gene Therapies Inc
4.40$
-2.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.00 | -1.74 | -3.11 | -2.01 | -0.63 | -0.32 | -0.29 | |
| 0.00 | 0.00 | 0.01 | 0.03 | 0.01 | 0.00 | 0.00 | |
| – | 0.19 | 0.48 | 0.41 | 0.07 | 0.05 | 0.04 | |
| 0.11 | 1.66 | 0.75 | 1.32 | – | – | – | |
| 0.01 | -0.01 | 0.76 | 0.42 | -0.16 | -0.05 | -0.02 | |
| 0.00 | 0.51 | 0.57 | 0.57 | 0.06 | 0.00 | 0.00 | |
| -0.25 | -0.51 | -0.57 | -0.57 | -0.06 | 0.00 | 0.00 | |
| – | 16.48 | – | – | – | – | – | |
| 1.08 | 2.26 | 1.06 | 0.00 | -0.03 | 0.00 | 0.03 | |
| 7.87 | 16.48 | 1.04 | 1.19 | 1.17 | 0.31 | 0.86 | |
| 0.00 | 14.22 | -2.64 | -1.39 | 0.48 | -0.02 | 0.57 | |
| 0.00 | -2.25 | -3.68 | -2.58 | -0.69 | -0.33 | -0.29 |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.